Basic Information
VIS ID
TVIS10011311
Fusion event
HBV-chr2 integration
Validated
No
Detection method
NGS
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2018
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Region type
Polymerase|
Start
2736
Orient
+
Integrated sequence
TTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAACATCTAGTTAATCATTACTTCCA| |AACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAA
Host Sequence
Chromosome
chr2
Cytoband
p14
Reference genome
End
68384966/68157834 (Hg38)
Orient
+
Location type
upstream
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-142-3p ; hsa-mir-1277-5p ; hsa-mir-190a-3p ; hsa-mir-5011-5p ; hsa-mir-7151-3p ; hsa-mir-6807-5p ; hsa-mir-5095 ; hsa-mir-6849-3p ; hsa-mir-4433a-3p ; hsa-mir-6504-3p ; hsa-mir-4433b-3p ; hsa-mir-4700-3p ; hsa-mir-129-5p ; hsa-mir-8055 ; hsa-mir-498 ; hsa-mir-4465 ; hsa-mir-26b-5p ; hsa-mir-26a-5p ; hsa-mir-1297 ; hsa-mir-1264 ; hsa-mir-8070 ; hsa-mir-6778-3p ; hsa-mir-4679 ; hsa-mir-1976 ; hsa-mir-3653-5p ; hsa-mir-150-5p ; hsa-mir-6747-3p ; hsa-mir-6727-3p ; hsa-mir-4722-3p ; hsa-mir-6814-5p ; hsa-mir-5697 ; hsa-mir-562 ; hsa-mir-1305 ; hsa-mir-607 ; hsa-mir-186-3p ; hsa-mir-4762-5p ; hsa-mir-5588-3p ; hsa-mir-6507-3p ; hsa-mir-4762-3p ; hsa-mir-6843-3p ; hsa-mir-6848-3p ; hsa-mir-640 ; hsa-mir-3192-3p ; hsa-mir-378a-5p ; hsa-mir-1193 ; hsa-mir-6759-3p ; hsa-mir-3151-3p ; hsa-mir-1237-3p ; hsa-mir-2392 ; hsa-mir-335-3p ; hsa-mir-3613-3p ; hsa-mir-4662a-5p ; hsa-mir-575 ; hsa-mir-4676-5p ; hsa-mir-6858-3p ; hsa-mir-4284 ; hsa-mir-4772-3p ; hsa-mir-4638-5p ; hsa-mir-1307-3p ; hsa-mir-1304-3p ; hsa-mir-6741-3p ; hsa-mir-1281 ; hsa-mir-4485-5p ; hsa-mir-4532 ; hsa-mir-1247-3p ; hsa-mir-6890-3p ; hsa-mir-122-3p ; hsa-mir-500a-3p ; hsa-mir-650 ; hsa-mir-3612 ; hsa-mir-6499-3p ; hsa-mir-2467-3p ; hsa-mir-6884-5p ; hsa-mir-485-5p ; hsa-mir-4487 ; hsa-mir-1827 ; hsa-mir-558 ; hsa-mir-5186 ; hsa-mir-3160-3p ; hsa-mir-17-3p ; hsa-mir-3664-3p ; hsa-mir-4433a-3p ; hsa-mir-4459 ; hsa-mir-4768-3p ; hsa-mir-92b-3p ; hsa-mir-92a-3p ; hsa-mir-367-3p ; hsa-mir-363-3p ; hsa-mir-32-5p ; hsa-mir-25-3p ; hsa-mir-6511a-5p ; hsa-mir-1910-3p ; hsa-mir-4695-5p ; hsa-mir-510-5p ; hsa-mir-106a-5p ; hsa-mir-106b-5p ; hsa-mir-17-5p ; hsa-mir-186-3p ; hsa-mir-20a-5p ; hsa-mir-20b-5p ; hsa-mir-302a-3p ; hsa-mir-302b-3p ; hsa-mir-302c-3p ; hsa-mir-302d-3p ; hsa-mir-302e ; hsa-mir-372-3p ; hsa-mir-373-3p ; hsa-mir-4731-5p ; hsa-mir-5089-5p ; hsa-mir-512-3p ; hsa-mir-519d-3p ; hsa-mir-520a-3p ; hsa-mir-520b ; hsa-mir-520c-3p ; hsa-mir-520d-3p ; hsa-mir-520e ; hsa-mir-520g-3p ; hsa-mir-520h ; hsa-mir-526b-3p ; hsa-mir-5589-5p ; hsa-mir-619-5p ; hsa-mir-6506-5p ; hsa-mir-93-5p
Nearest miRNA
hsa-mir-1301/Upstream/1799506; hsa-mir-10b/Downstream/945848;
Nearest CpG islands
chr2-CpG: 70/Target, None/Upstream, None/Downstream
Upstream sequence
GGAGTGAGCCCAAGACCATCAGGCATATCTTAGGACAGCCTAACCCCGTTTTCCCCCCCACCGGCCCCAAATCCTGCAGGTCCCCGGCCTGTGACGTTTT
Downstream sequence
AGGAAAGGGGCGGAGCTGCAGGGGTGGTTGGCTGAGGCTGGCTTCTGCGTGGTGCAGCTGCGCACGTGTTTCAGCCGGCAGCGCTTTAAGATTTCCGGGG
Reference
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.
Curate